{
  "categories": [
    {
      "id": "geriatric-syndromes",
      "title": "Geriatric Syndromes",
      "description": "Common clinical conditions in older adults that don't fit into discrete disease categories",
      "topics": [
        {
          "id": "falls-prevention",
          "title": "Falls and Fall Prevention",
          "content": "Falls are the leading cause of injury-related deaths in adults aged 65+. Risk factors include muscle weakness, vitamin D deficiency, vision problems, medications (especially psychotropics), and environmental hazards.",
          "keyPoints": [
            "Conduct comprehensive fall risk assessments using tools like Morse Fall Scale",
            "Implement multifactorial interventions: exercise, medication review, vision correction",
            "Home safety modifications: grab bars, adequate lighting, removing trip hazards",
            "Vitamin D supplementation (800-1000 IU daily) reduces fall risk by 19%",
            "Tai Chi and balance training reduce falls by 20-30%"
          ],
          "guidelines": "AGS/BGS Clinical Practice Guideline 2022",
          "cmeCredits": 1.5
        },
        {
          "id": "delirium-management",
          "title": "Delirium Recognition and Management",
          "content": "Delirium affects up to 50% of hospitalized older adults. It's associated with increased mortality, prolonged hospitalization, and cognitive decline.",
          "keyPoints": [
            "Use CAM (Confusion Assessment Method) for screening",
            "Identify and treat underlying causes: infections, medications, metabolic disturbances",
            "Non-pharmacological interventions first: reorientation, sleep hygiene, early mobilization",
            "Avoid benzodiazepines except for alcohol withdrawal",
            "Low-dose antipsychotics only for severe agitation posing safety risk"
          ],
          "guidelines": "NICE Guideline CG103",
          "cmeCredits": 2.0
        },
        {
          "id": "polypharmacy",
          "title": "Polypharmacy and Deprescribing",
          "content": "Polypharmacy (≥5 medications) affects 40% of older adults and increases risk of adverse drug events, falls, and hospitalizations.",
          "keyPoints": [
            "Regular medication reconciliation at every visit",
            "Use STOPP/START criteria for inappropriate prescribing",
            "Consider deprescribing when benefits no longer outweigh risks",
            "Beers Criteria for potentially inappropriate medications",
            "Patient-centered approach: align medications with goals of care"
          ],
          "guidelines": "AGS Beers Criteria 2023",
          "cmeCredits": 1.5
        },
        {
          "id": "frailty-assessment",
          "title": "Frailty Assessment and Interventions",
          "content": "Frailty affects 10-15% of community-dwelling older adults and up to 50% in nursing homes. It's characterized by decreased physiologic reserve.",
          "keyPoints": [
            "Fried Frailty Phenotype: weight loss, exhaustion, low activity, slowness, weakness",
            "Clinical Frailty Scale for rapid assessment",
            "Comprehensive Geriatric Assessment for frail patients",
            "Multicomponent interventions: nutrition, exercise, social support",
            "Frailty is potentially reversible with early intervention"
          ],
          "guidelines": "International Conference on Frailty and Sarcopenia Research",
          "cmeCredits": 2.0
        }
      ]
    },
    {
      "id": "cognitive-disorders",
      "title": "Cognitive Disorders",
      "description": "Diagnosis and management of dementia and cognitive impairment",
      "topics": [
        {
          "id": "alzheimers-disease",
          "title": "Alzheimer's Disease: Current Management",
          "content": "Alzheimer's disease accounts for 60-80% of dementia cases. Early diagnosis and comprehensive management improve quality of life.",
          "keyPoints": [
            "Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) for mild-moderate stages",
            "Memantine for moderate-severe stages, can combine with ChEIs",
            "New drugs: Aducanumab and Lecanemab - controversial efficacy",
            "Non-pharmacological interventions: cognitive stimulation, exercise, music therapy",
            "Caregiver support and education crucial for outcomes"
          ],
          "guidelines": "AAN Practice Parameter Update 2023",
          "cmeCredits": 2.5
        },
        {
          "id": "vascular-dementia",
          "title": "Vascular Dementia Prevention and Management",
          "content": "Second most common dementia type, often coexists with Alzheimer's. Focus on vascular risk factor modification.",
          "keyPoints": [
            "Aggressive blood pressure control (<130/80 mmHg)",
            "Antiplatelet therapy for stroke prevention",
            "Statin therapy for dyslipidemia",
            "Diabetes management with HbA1c <7%",
            "No specific medications approved; manage symptoms"
          ],
          "guidelines": "AHA/ASA Scientific Statement 2021",
          "cmeCredits": 1.5
        },
        {
          "id": "lewy-body-dementia",
          "title": "Lewy Body Dementia: Recognition and Treatment",
          "content": "Third most common dementia, characterized by fluctuating cognition, visual hallucinations, and parkinsonism.",
          "keyPoints": [
            "Core features: fluctuating cognition, visual hallucinations, REM sleep behavior disorder, parkinsonism",
            "Severe neuroleptic sensitivity - avoid typical antipsychotics",
            "Rivastigmine may help cognition and hallucinations",
            "Quetiapine or clozapine for psychosis if needed",
            "Melatonin for REM sleep behavior disorder"
          ],
          "guidelines": "DLB Consortium Fourth Report 2023",
          "cmeCredits": 2.0
        }
      ]
    },
    {
      "id": "medication-management",
      "title": "Geriatric Pharmacology",
      "description": "Safe prescribing practices for older adults",
      "topics": [
        {
          "id": "pharmacokinetics-aging",
          "title": "Age-Related Pharmacokinetic Changes",
          "content": "Aging affects drug absorption, distribution, metabolism, and excretion, requiring dose adjustments.",
          "keyPoints": [
            "Decreased renal function: use Cockcroft-Gault or CKD-EPI for dosing",
            "Reduced hepatic metabolism: lower doses of hepatically cleared drugs",
            "Increased fat:lean ratio affects drug distribution",
            "Decreased albumin increases free drug levels",
            "Start low, go slow principle for dose titration"
          ],
          "guidelines": "FDA Guidance for Industry 2020",
          "cmeCredits": 1.5
        },
        {
          "id": "pain-management",
          "title": "Pain Management in Older Adults",
          "content": "Chronic pain affects 50% of community-dwelling and 80% of nursing home residents.",
          "keyPoints": [
            "Acetaminophen first-line, max 3g/day (2g if liver disease)",
            "Avoid NSAIDs if possible; use shortest duration, lowest dose",
            "Topical agents for localized pain (capsaicin, lidocaine, diclofenac)",
            "Opioids: start with short-acting, avoid meperidine and propoxyphene",
            "Multimodal approach: physical therapy, CBT, acupuncture"
          ],
          "guidelines": "AGS Guidelines on Persistent Pain 2023",
          "cmeCredits": 2.0
        },
        {
          "id": "anticoagulation",
          "title": "Anticoagulation in the Elderly",
          "content": "Balancing stroke prevention with bleeding risk in atrial fibrillation and VTE.",
          "keyPoints": [
            "DOACs preferred over warfarin for most indications",
            "Dose adjustments based on renal function, weight, age",
            "Fall risk alone not contraindication if CHA2DS2-VASc ≥3",
            "Regular reassessment of risks vs benefits",
            "Reversal agents: idarucizumab (dabigatran), andexanet alfa (Xa inhibitors)"
          ],
          "guidelines": "ACC/AHA/HRS Guideline 2023",
          "cmeCredits": 1.5
        }
      ]
    },
    {
      "id": "preventive-care",
      "title": "Preventive Care and Screening",
      "description": "Evidence-based screening and prevention for older adults",
      "topics": [
        {
          "id": "cancer-screening",
          "title": "Cancer Screening in Older Adults",
          "content": "Individualized approach based on life expectancy, functional status, and patient preferences.",
          "keyPoints": [
            "Breast cancer: mammography to age 74, then individualized",
            "Colorectal: screen to age 75, selective 76-85, stop after 85",
            "Cervical: stop at 65 if adequate prior screening",
            "Prostate: shared decision-making, consider stopping at 70",
            "Lung: annual CT for smokers 50-80 with 20 pack-year history"
          ],
          "guidelines": "USPSTF Recommendations 2023",
          "cmeCredits": 1.5
        },
        {
          "id": "immunizations",
          "title": "Immunizations for Older Adults",
          "content": "Vaccines are crucial for preventing morbidity and mortality in older adults.",
          "keyPoints": [
            "Influenza: high-dose or adjuvanted vaccine annually",
            "Pneumococcal: PCV20 or PCV15 followed by PPSV23",
            "Herpes zoster: Shingrix (2 doses) for all ≥50 years",
            "COVID-19: stay up-to-date with boosters",
            "Tdap: once, then Td every 10 years"
          ],
          "guidelines": "ACIP Recommendations 2024",
          "cmeCredits": 1.0
        },
        {
          "id": "bone-health",
          "title": "Osteoporosis Screening and Treatment",
          "content": "Osteoporosis affects 25% of women and 5% of men over 65, leading to fractures.",
          "keyPoints": [
            "DEXA screening: women ≥65, men ≥70, younger if risk factors",
            "FRAX tool for 10-year fracture risk assessment",
            "Calcium 1200mg and Vitamin D 800-1000 IU daily",
            "Bisphosphonates first-line, consider drug holiday after 5 years",
            "Denosumab, teriparatide for severe osteoporosis"
          ],
          "guidelines": "AACE/ACE Guidelines 2023",
          "cmeCredits": 1.5
        }
      ]
    },
    {
      "id": "end-of-life",
      "title": "Palliative and End-of-Life Care",
      "description": "Compassionate care for serious illness and end of life",
      "topics": [
        {
          "id": "advance-care-planning",
          "title": "Advance Care Planning Conversations",
          "content": "Early discussions about goals, values, and preferences improve end-of-life care quality.",
          "keyPoints": [
            "Start conversations early when cognitive capacity intact",
            "Use SPIKES protocol for difficult conversations",
            "Document in advance directives: living will, healthcare proxy",
            "POLST/MOLST for seriously ill patients",
            "Regular reassessment as health status changes"
          ],
          "guidelines": "National POLST Paradigm 2023",
          "cmeCredits": 2.0
        },
        {
          "id": "symptom-management",
          "title": "Symptom Management at End of Life",
          "content": "Addressing pain, dyspnea, anxiety, and other symptoms in final days.",
          "keyPoints": [
            "Pain: morphine gold standard, use breakthrough doses",
            "Dyspnea: opioids effective, oxygen only if hypoxemic",
            "Delirium: haloperidol for hyperactive, supportive care",
            "Secretions: repositioning, glycopyrrolate, avoid suctioning",
            "Anxiety: lorazepam sublingual or subcutaneous"
          ],
          "guidelines": "NCCN Palliative Care Guidelines 2023",
          "cmeCredits": 2.0
        },
        {
          "id": "hospice-referral",
          "title": "Hospice Referral and Eligibility",
          "content": "Hospice improves quality of life and may extend survival in some conditions.",
          "keyPoints": [
            "Prognosis ≤6 months if disease follows expected course",
            "Disease-specific criteria: cancer, dementia, heart failure, COPD",
            "General indicators: functional decline, weight loss, infections",
            "Can continue disease-modifying therapy if comfort-focused",
            "Family satisfaction higher with earlier referral"
          ],
          "guidelines": "Medicare Hospice Conditions of Participation",
          "cmeCredits": 1.5
        }
      ]
    },
    {
      "id": "functional-assessment",
      "title": "Functional and Social Assessment",
      "description": "Comprehensive evaluation of function and social determinants",
      "topics": [
        {
          "id": "adl-iadl-assessment",
          "title": "ADL and IADL Assessment Tools",
          "content": "Functional assessment predicts outcomes and guides care planning.",
          "keyPoints": [
            "Katz ADL: bathing, dressing, toileting, transferring, continence, feeding",
            "Lawton IADL: shopping, housework, finances, medications, phone, transport",
            "Performance-based: Timed Up and Go, gait speed, grip strength",
            "Functional decline often first sign of illness",
            "Regular reassessment to track changes"
          ],
          "guidelines": "CMS Annual Wellness Visit Requirements",
          "cmeCredits": 1.0
        },
        {
          "id": "social-isolation",
          "title": "Social Isolation and Loneliness",
          "content": "Social isolation increases mortality risk equivalent to smoking 15 cigarettes daily.",
          "keyPoints": [
            "Screen with UCLA Loneliness Scale or single question",
            "Risk factors: living alone, mobility limitations, sensory impairment",
            "Health impacts: depression, cognitive decline, cardiovascular disease",
            "Interventions: social prescribing, technology training, group activities",
            "Community resources: senior centers, volunteer programs"
          ],
          "guidelines": "National Academies Report 2020",
          "cmeCredits": 1.5
        },
        {
          "id": "caregiver-assessment",
          "title": "Caregiver Burden and Support",
          "content": "Family caregivers provide 80% of long-term care but often experience burnout.",
          "keyPoints": [
            "Zarit Burden Interview for assessment",
            "Signs: depression, anxiety, physical health decline",
            "Respite care crucial for caregiver wellbeing",
            "Education about disease process and resources",
            "Support groups and counseling services"
          ],
          "guidelines": "National Alliance for Caregiving 2023",
          "cmeCredits": 1.5
        }
      ]
    }
  ],
  "certifications": [
    {
      "id": "cert-geriatrics",
      "title": "Certificate in Geriatric Medicine",
      "provider": "American Geriatrics Society",
      "duration": "6 months",
      "credits": 50,
      "modules": [
        "Comprehensive Geriatric Assessment",
        "Geriatric Syndromes",
        "Dementia Care",
        "Palliative Care",
        "Geriatric Pharmacology"
      ]
    },
    {
      "id": "cert-dementia",
      "title": "Dementia Care Specialist",
      "provider": "Alzheimer's Association",
      "duration": "3 months",
      "credits": 25,
      "modules": [
        "Dementia Diagnosis",
        "Behavioral Management",
        "Communication Strategies",
        "Care Planning",
        "Family Support"
      ]
    }
  ],
  "resources": {
    "guidelines": [
      {
        "title": "AGS Beers Criteria 2023",
        "url": "https://www.americangeriatrics.org/beers-criteria",
        "type": "PDF"
      },
      {
        "title": "STOPP/START Criteria Version 2",
        "url": "https://www.eugms.org/stopp-start",
        "type": "PDF"
      },
      {
        "title": "CDC STEADI Fall Prevention",
        "url": "https://www.cdc.gov/steadi",
        "type": "Toolkit"
      }
    ],
    "journals": [
      "Journal of the American Geriatrics Society",
      "The Gerontologist",
      "Age and Ageing",
      "Clinical Interventions in Aging"
    ],
    "organizations": [
      "American Geriatrics Society (AGS)",
      "Gerontological Society of America (GSA)",
      "International Association of Gerontology and Geriatrics (IAGG)",
      "National Institute on Aging (NIA)"
    ]
  }
}